Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in wound healing after mandibular third molar removal
NCT02831374Phase 1Completed
- Sponsor
- Linyi People's Hospital
- Start
- Oct 2015
- Primary completion
- Mar 2016
- Modality
- Hydrogel Systems, Cell Therapies
01
Overview
Phase 1, randomised, single-blind trial of autologous platelet rich gel in impacted third molar (I3M), sponsored by Linyi People's Hospital. Primary endpoint: Postoperative Pain at 14 days. Started Oct 2015; status: completed.
02
Drugs
autologous platelet rich gel
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT02831374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02831374.